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A Therapy Imaging and Model Management System
(TIMMS) is an information technology (IT) concept and
framework for the collection, organization, and utiliza-
tion of medical information from sources such as the
Electronic Medical Record (EMR), PACS, etc. TIMMS
was originally designed as a surgical assist system, but
has many general medical uses as well, including all
forms of Model-Guided Medicine and may therefore be
generalized to a medical information and model man-
agement system [1].
Functionally, a TIMMS provides the following function-
alities throughout the course of medical or therapeutic
treatment (by means of interconnected engines, agents,
repositories, and IT infrastructure) (Fig. 1):
a) Creation and maintenance of a Patient-Specific
Model, thereby providing a multi-scalar, comprehensive,
precise, personalized representation of the patient,
b) Real-time knowledge management and decision sup-
port system thereby promoting optimized diagnostic,
prognostic and therapeutic decisions throughout the
treatment workflow,
c) Validation system thereby providing quality assurance,
patient safety, system security and processing of
medical evidence, and
d) Standardized interfaces for communication and mecha-
tronics, thereby creating a unified environment for the
input and output of data (including the representation
and display of information and images, as well as the
electromechanical control of interventional and navi-
gational devices).
Fig. 1 TIMMS IT Reference Architecture (WF: workflow, EBM: evidence based medicine)
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The Patient-Specific Model (PSM) is the central construct
for a patient within a personalized medicine environment,
in order to provide a clinician with a real-time representation
of critical information about the patient. The data of the
Patient-Specific Model reside within a Probabilistic Patient-
Specific Database (PPD) [2]. The fields of the database consist
of
a) absolute patient attributes such as name, medical record
number, etc.,
b) descriptive patient attributes, such as medical images;
graphical physiological information, such as ECG or
EEG; physiological values within expected value
ranges; results of biochemical and biomedical model-
ing, in the form of results of equations; pathological
findings, etc.; and,
c) probabilistic patient attributes, such as probability of
tumor response to treatment, which are expressed in
terms of probability and confidence level; conditional
tables; etc.
A multi entity Bayesian network (MEBN) allows the
graphing of an unlimited number of relationships between
the fields within the PPD. Real-time function of a Patient-
Specific Model will require the development or modifica-
tion of a new form of database: a probabilistic database
which will allow the utilization of probabilistic data
structure, which will incorporate a database design and a
database management system which allows probabilistic
database functions and storage capabilities.
A probabilistic database is a database representing uncer-
tainties in which the possible worlds have associated
probabilities. Probabilistic database management systems
are an active area of research. While there are currently no
commercial probabilistic database systems, several research
prototypes exist [2].
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The individualization of medicine and healthcare appears to
be following a general societal trend [1]. The terms
“personalised medicine” and “personal health” are used to
describe this process. It must be emphasised, however, that
personalised medicine is not limited to pharmacogenomics
as it is sometimes defined [2], but that the spectrum of
methods and tools for personalised medicine is much
broader, see Fig 1.
Applications range from individualised diagnostics, patient-
specific pharmacological therapy, therapy with individual
prostheses and implants, Fig. 2, to therapy approaches
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Fig. 1. Spectrum of methods and tools for personalised medicine
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therapy in the operating room, Fig 3, including electronic
patient records [3] to the individual care of patients in their
home environment [4] with the use of technical systems
and services.
Although in some areas practical solutions have already
been developed, most applications will not have fully
evolved for many years to come.
Medical and information technologies are essential to
personalised medicine and personal health. The syner-
gy of these two technologies provides the basis for
most tools and systems employed in individualised
medicine.
Based on an overview on methods and tools and the general








19601950 1970 1980 1990 2000 2010
fixed frequency


































EBM – Evidence-based medicine
MBME – Model-based medical evidence
IHE – Integrating the healthcare enterprise
Fig. 3. Patient specific modelling for a model based medicine
EPMA Journal (2011) 2 (Suppl 1):S181–S187 S183
beneficial applications of ICT in personalised medicine are
exemplified in this paper.
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The refractive surgery is well established treatment of
various vision lesions. In spite of tremendous techno-
logical developments, not always the results are satis-
factory. Computer-assisted modeling of ocular
parameters can be used to estimate results of refractive
surgery. Laser in situ keratomileusis (LASIK) is the
most widely used ophthalmic surgical technique to
correct refractive errors. The technique is mainly used
to treat myopia, hyperopia and astigmatism. The goal of
refractive surgery is to reduce the refractive error and
correct vision. Even though LASIK outcomes are
usually quite satisfactory, complications like uncompen-
sated refractive errors, visual aberrations or irregular
astigmatism may occur. Usually, before the procedure
refractive error, ocular astigmatism, corneal topography
and central corneal thickness of the eye, are measured.
However, the surgery is usually based on general,
averaged statistical data from wider population. Individ-
ual features of human eyes such as rigidity of ocular
tissues can also influence the surgery outcomes. There-
fore some uncompensated refractive errors may occur
after LASIK procedure.
Development of numerical analysis methods creates possi-
bility to individualize LASIK procedure. Finite elements
method was used to analyze the influence of individual
corneal properties on the effect of LASIK surgery. Corneal
geometry including radii and pachymetry, as well as biome-
chanical properties of the tissue were taken into account
during modeling. The photoablation process cause changes in
geometry of the anterior corneal surface and the corneal
thickness. However, medical procedures do not consider the
influence of intraocular pressure (IOP) on geometry of
postoperated cornea. Our calculations predict how different
values of IOP influence the geometry of corneal surface
before and after LASIK. Nonlinear stress-strain characteristics
of cornea were taking to account. In the physiological range of
the intraocular pressure (10–20 mmHg), a linear relationship
between IOP value and the cornea displacement was found.
For modeling of the optical properties of human eye, the
software ZEMAX® was applied. Quality of retinal image
was assessed for modeling of the individualized eye before
and after LASIK. Spot-diagrams and optical transfer
functions (OTFs) were analyzed, as well.
Combining mechanical and optical modeling of human eye
may lead to better understanding of the relations existing
between IOP, corneal geometry and rigidity, as well as
retinal image quality. Our investigation can help to improve
process of planning LASIK surgery. Taking into the
consideration individual properties of human eye, it may
help minimize postoperative refractive errors.
MEANINGFUL USE OF PATIENT-CENTRIC
HEALTH RECORDS FOR PERSONALIZED
MEDICINE
Shabo (Shvo) A
IBM Research Lab in Haifa, Israel
The success of personalized medicine (PM) for the care of a
patient is dependent on effective use of PM knowledge (e.g.,
pharmacogenomic interpretation of somatic mutations in
tumor tissues) while considering the full-blown description
of the patient’s past medial history (e.g., existing mutations
associated with observed responsiveness to certain drugs). In
order for PM knowledge to be effectively applied to the
patient medical records, the latter needs to be as rich as
possible and more importantly, semantics of medical data
should be made explicit and machine-processable [1]. Often,
semantics of research & clinical data is represented implicitly,
and is hidden in unstructured and disconnected descriptions of
the data or just in the heads of human experts (researchers and
caregivers).Meaningful semantics includes richmetadata, i.e.,
the predefined structure of data in medical records. In
addition, it is extremely important to explicitly represent the
patient-specific context of each discrete data item and how it
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relates to other data items, as well as how it fits within the
entire health history of an individual. Dispersed and disparate
medical records of a patient are often inconsistent and
incoherent. A patient-centric longitudinal electronic health
record (EHR) based on international standards (e.g., CEN
EHR 13606 [2]) could provide coherent and explicit
representation of the data semantics. New PM evidences
generated by clinical research and validated in clinical trials
should be represented in alignment with clinical data
representations in a way that lends itself to personalized
medicine realization. A constantly growing stream of raw data
is available today in both research and clinical environments,
e.g., DNA sequences along with rare variants in research and
sensor data along with personal alerts in healthcare. The
representation of such raw data should adhere as much as
possible to common and agreed-upon reference models (e.g.,
HL7/ISORIM –Reference InformationModel [3]) so that, for
example, any observation is represented in the same way in
terms of its attributes such as id, timing, code, value, method
and status, as well as standard representation of clinical
statements (e.g., observation of gall bladder acute inflamma-
tion indicated procedure of cholecystectomy or EGFR
variations cause resistance to Gefitinib), where implicit
semantics can become explicit and thus processable by
decision support applications.
A patient-centric EHR could span across the individual’s
lifetime but is practically nonexistent today because none of
the existing stakeholders in the health world (i.e., healthcare
providers, insurers, government agencies and the patients)
can sustain such an information entity due to lack of
information technologies expertise as well as conflict of
interests. The inevitable solution is for healthcare providers
to stop being the legal record keepers and let new entities
(independent health record banks - IHRB) be the sole health
record keepers, sustaining a single EHR for an individual no
matter where this individual has been treated. There should
be multiple and competing IHRBs that will be regulated by
new legislation that shifts the obligation of medical record
keeping from healthcare providers to IHRBs [4].
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Predictive, preventive and personalised medicine (PPPM) has
emerged as the advanced concept for the medicine of the 21st
century and it receives widespread international acceptance.
The information gathered in the healthcare and related
fields becomes more complex than any time in the history
of medicine, and it is expected to encompass even more
data thanks to the “omics” fields, complemented by the data
on the nutrition components, herbal components, medical
drugs, and the data on the particular interrelations between
all the components. Continually increasing complexity
of medical information in healthcare together with the
rising impact of the PPPM clearly catalyses closer
cooperation between medicine, informatics, mathematics,
software engineering, communication technology, statistics,
complexity science, linguistics, ethics and other the related
fields.
Due to the amount of the relevant medical data on the
particular patient produced in the process of the analysis of the
patient’s biological material, the role of laboratory diagnostics
in the PPPM is fundamental and it is potentiated by the latest
information technologywhichmust be actively engaged in the
process of computer assisted diagnostics, decision making,
data and knowledge mining, text mining, knowledge seman-
tics and knowledge structuring, model-based prediction,
individual prevention and treatment suggestions. More active
assistance in data processing is essentially needed in the
preanalytical and postanalytical phases, both of which are
vital for the reliable result interpretation in the laboratory
diagnostics. By complex analysing of the patient’s results
and related data, the computers should be able to offer
“second opinion”, based on the relevant knowledge
traceable in the scientific literature and the referential
knowledge bases. In the future, we should have functional
interactive models for an individual patient’s health,
allowing us to predict potential health problems under
diverse model situations.
The active processing of complex information in healthcare
and life sciences is crucial and provides reliable knowledge
for understanding the complexity of interactions among all
components of an individual human body, thus facilitating
the potential for plausible predictions, prevention and
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consequent medical decisions related to the individual
patient. Any potential success in this respect, on the other
hand, brings considerable ethical questions we have to
solve, prior to ever taking the “wrong path”.
The investigation of the predictive and preventive potential
of the new tools in in-vitro and in-vivo diagnostics, and
consequent evaluation and implementation of these tools in
the daily healthcare, must progress in concert with in-silico
diagnostics - active computer processing of acquired
analytical data, patient profile data, medical information
and other related data in order to suggest reliable prediction
for the benefit of the patient, or better say for the benefit of
an individual person who, thanks to the prediction and
preventive actions, may, hopefully, avoid the state of being
called “a patient”.
MULTILEVEL, MULTISOURCE BIO- MEDICAL
RULE DISCOVERY SYSTEM – ESSENTIAL
ENABLER TO PREVENTIVE, PREDICTIVE
AND PERSONALIZED MEDICINE
Marcus-Kalish M, Gozes I
Interdisciplinary Center for Technology Analysis and
Forecasting, Tel Aviv University, Israel
The revolutionary trends in scientific research in general, and
Bio-Medical research in particular, have provided new and
profound insights into multiple levels and various degrees of
sensitivity to the human body functioning in its surroundings.
Newly developed invasive and non-invasive tools based on
“converging technologies” and the capturing of massive
amounts of information have created a crucial need for
advanced, innovative and specially tailored analysis tools.
That is in order to utilize all available knowledge and
translate it into the optimum practice of preventive,
predictive & personalized medicine.
The analytical tools that coincided with a spectacular
progress in the quality and accuracy of health care must
adjust, for example, to the unexpected predominance of
chronic degenerative disease characterized by high com-
plexity, non-linearity, etc.
New philosophical approach as well as new innovative analysis
tools specially developed to meet these needs has to be taken.
The goal is to enable the “whole approach” - a simulta-
neous systematic analysis providing the broad insight on
various phenomena in order to reveal the underlying rules.
The coupling of computer sciences, complexity theory, non
linear dynamics and logic theory lead to the development of
learning machine that extract the underlying rules and thus
facilitates prediction that improves its accuracy while in
usage.
A new Data Mining rule discovery tool was specially
developed to meet these goals and the above mentioned
needs and constrains in Bio-Medical applications. The
tool enables simultaneous analysis of multilevel, multi-
source data (images, numeric, signals, categorical,
descriptive data, etc) while relating to the whole data
set as is – which is crucial to the “whole system”
approach. Further more it minimizes over- fitting,
usually a major barrier - small data sets with many
parameters.
Following these constrains the patented algorithm is proven
to reveal:
– All If Than tools and all If than Not tools that meets the
predefined threshold
– An optimal subset of If and Only If (necessary and
sufficient conditions)
– A subset of If and Only If Not rules utilized as a
screening tool to identify specific targets.
– A set of unexpected rules and cases.
The tool was already applied successfully to autoimmune
diseases, degenerative diseases, ethnic group analysis as
well as structural biology, drug development, personalized
skin treatment, drug penetration, neuronal biomarkers, etc.
In Alzheimer patients, for example, the tool enables
combined analysis of imaging data, signals, numerical and
categorical data (laboratory tests) descriptive data (patient
history), etc.
A special example of the Cerebellar conditioning modelling
was applied providing insight into the learning mechanism -
“BCI accelerates learning by timing the delivery of
stimuli”.
Understanding of the neuronal coding of sensory events
holds the opportunity to bi-directionally interface the brain
sensory system to a smart BCI, with the objective to
rehabilitate or enhance the learning of sensory events. The
bi-directional interface may be beneficial for individuals
with localized neuronal degeneration or brain injury. At the
present study motor learning was accelerated by online BCI
tuned to deliver sensory events during the ‘optimal’ brain
state.
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The majority of processes found in medicine are nonlinear,
chaotic, have a high level of complexity. The decisions in
healthcare are often stereotyped, managed by habits
preferences, previous experience and official directives.
These decisions might be not completely conscious.
In our current study, we made attempts to bring a system
into this process. Each stage requires creation some
mathematical models that might be described by general-
ized equation. These equations can be could be solved in
closed system. We do not aim at finding absolute solutions,
its statistically calculated optimal way of solution, but
accent on a special mood, the state of expert, which could
give a possibility to make only one correct decision with
failure in input parameters. In such cases the lack of prior
data is compensated by doctor’s experience. A great value
for our vision had a study of neurophysiological mecha-
nisms of perception and decision making by medical
practitioner. For example, at stage of visual diagnostics
in order to expand its diagnostic capabilities, to reduce
subjectivity in the perception and interpretation, we imple-
mented the method of fractal analysis the medical images. It
becomes a highly informative indicator of pathological
formations, using nonlinear mathematical parameters of
structure. This method requires expert medical approach,
which is more objective than existing automated. It can be
applied in all areas of medicine, where the visual information
is used, mostly in oncology. Fractal analysis may become a
dominant factor in predicting outcome of doubtful clinical
conditions. According to preliminary results, the malignant
formations have higher fractal dimension. For modeling the
stage of decision making, errors analysis and for predicting
procedure risk we studied the negative selection of variants of
prognostic indicators of interventional sonography mistakes
as a combinatorial optimization problem (as the task on the
graph) and was solved, using algorithmic scheme for the
method of branches and boundaries using own designed
phantoms. In the absence of experimental data the expert
method of assessment by independent specialists was applied.
Studying the error on phantoms, we concluded that in some
situations that anyway mistake was admitted by performers,
regardless of adherence to conventional methods. The reason
for such errors can be called fatigue, coordination disorders
etc. These parameters could not amenable to analysis and
interpreted using linear methods. In this case we suggest to
explore the problem using the method of diffusion equation of
bifurcation. The reproducible errors model could potentially
help to prevent iatrogenic injury in clinical situations,
excluding any stereotypical, unconscious decision, to formu-
late methodological aspects of intervention and initiate
flexible upgrading of clinical protocols.
Fig. 1 % Eyeblink CRs (Mean ± SE) along five sessions of eyeblink conditioning in algorithm treated group and yoked control group. The
algorithm group significantly outperformed the conditioning in the control group. (all comparisons are Bonferroni corrected)
* Significant increase in comparison to the 1st session, p<0.02.
¥ Significant increase in comparison to the control group, p<0.001.
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